NCT02378194View on ClinicalTrials.gov

Change From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Chronic Renal Failure
Interventions
DRUG

Placebo

24 weeks, once daily oral administration

DRUG

HD-003 (800mg/day)

24 weeks, once daily oral administration

DRUG

HD-003 (1600mg/day)

24 weeks, once daily oral administration

Sponsors
All Listed Sponsors
lead

Hyundai Pharmaceutical Co., LTD.

INDUSTRY